AngioDynamics Inc (ANGO)
6.265
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
6.265
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Enterprise Value: 172.49M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 172.49M |
| April 19, 2024 | 172.29M |
| April 18, 2024 | 166.68M |
| April 17, 2024 | 175.09M |
| April 16, 2024 | 182.30M |
| April 15, 2024 | 174.29M |
| April 12, 2024 | 176.70M |
| April 11, 2024 | 193.92M |
| April 10, 2024 | 195.92M |
| April 09, 2024 | 200.73M |
| April 08, 2024 | 186.31M |
| April 05, 2024 | 205.73M |
| April 04, 2024 | 180.27M |
| April 03, 2024 | 167.33M |
| April 02, 2024 | 171.78M |
| April 01, 2024 | 157.22M |
| March 28, 2024 | 158.84M |
| March 27, 2024 | 151.97M |
| March 26, 2024 | 139.84M |
| March 25, 2024 | 134.59M |
| March 22, 2024 | 138.22M |
| March 21, 2024 | 144.69M |
| March 20, 2024 | 147.52M |
| March 19, 2024 | 145.90M |
| March 18, 2024 | 139.44M |
| Date | Value |
|---|---|
| March 15, 2024 | 138.63M |
| March 14, 2024 | 140.25M |
| March 13, 2024 | 146.31M |
| March 12, 2024 | 143.48M |
| March 11, 2024 | 142.67M |
| March 08, 2024 | 150.76M |
| March 07, 2024 | 153.99M |
| March 06, 2024 | 146.71M |
| March 05, 2024 | 148.73M |
| March 04, 2024 | 145.50M |
| March 01, 2024 | 143.88M |
| February 29, 2024 | 143.48M |
| February 28, 2024 | 167.47M |
| February 27, 2024 | 177.84M |
| February 26, 2024 | 171.86M |
| February 23, 2024 | 169.87M |
| February 22, 2024 | 177.84M |
| February 21, 2024 | 173.85M |
| February 20, 2024 | 181.03M |
| February 16, 2024 | 185.81M |
| February 15, 2024 | 185.01M |
| February 14, 2024 | 181.82M |
| February 13, 2024 | 177.44M |
| February 12, 2024 | 187.00M |
| February 09, 2024 | 181.82M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
134.59M
Minimum
Mar 25 2024
1.187B
Maximum
Nov 05 2021
596.04M
Average
546.54M
Median
Oct 27 2022
Enterprise Value Benchmarks
| Becton Dickinson & Co | 82.50B |
| Integer Holdings Corp | 4.833B |
| Outset Medical Inc | 44.47M |
| Perspective Therapeutics Inc | 890.47M |
| Xtant Medical Holdings Inc | 125.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -187.74M |
| Revenue (Quarterly) | 75.18M |
| Total Expenses (Quarterly) | 86.78M |
| EPS Diluted (Quarterly) | -4.67 |
| Gross Profit Margin (Quarterly) | 47.70% |
| Profit Margin (Quarterly) | -249.7% |
| Earnings Yield | -76.30% |
| Normalized Earnings Yield | -10.91 |